Acorda Therapeutics, Inc.

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

Report date

9/30/2020

Quarter

2020 Q3

Filed

11/12/2020

Shares

286,500

Value ($000)

148

Weight

0.0%

2019 Q4 - 2020 Q3 (3 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2020 Q3	11/12/2020	148	0.0%	286,500	9/30/2020
2020 Q2	8/12/2020	429	0.0%	584,200	6/30/2020
2019 Q4	2/13/2020	293	0.0%	143,735	12/31/2019